Mehdi S Mirsaeidi, MD, MPH
Professor; Chief, Division Of Pulmonary, Critical Care & Sleep Medicine
Department:
Medicine – Jacksonville
Business Phone:
(904) 244-8846
Business Email:
mehdi.mirsaeidi@jax.ufl.edu
About Mehdi S Mirsaeidi
Mehdi Mirsaeidi, M.D., M.P.H., has completed training in internal medicine, infectious disease and pulmonary and critical care medicine. He pursued training in interstitial lung disease, or ILD, and sarcoidosis at the University of Illinois at Chicago. In 2015, Dr. Mirsaeidi joined the University of Miami and, as a member of ILD program, he developed Sarcoidosis Center of Excellence at the university.
In 2021, he joined the Division of Pulmonary, Critical Care and Sleep Medicine at the University of Florida College of Medicine – Jacksonville as division chief. Dr. Mirsaeidi is also director of the ILD and Sarcoidosis Program at UF Health in Jacksonville.
Dr. Mirsaeidi has continuously contributed to a number of publications from international research groups, highlighting his multi-disciplinary approach to complex medical questions. He has established a vibrant and productive research team in the Division of Pulmonary and Critical Care. His current role has allowed him to develop strong relationships with many disciplines with all relevant sectors from medical staff, researchers, patients and policy makers.
Dr. Mirsaeidi is an active member of many respiratory societies in the U.S. and Europe. In addition, he serves on the editorial board of numerous pulmonary journals, some of which he holds leadership roles. Dr. Mirsaeidi is a scientific reviewer for many major journals and national and international extramural funding agencies.
His lab is interested in studying novel biomarkers that are involved in the mechanism of sarcoidosis, ILD and lung cancer. His team has discovered role of GHRHR in inflammation and lung cancer with a focus on small cell lung cancer (SCLC).
Additional Positions:
Professor of Medicine
2021 – Current
·
University of Florida
Chief, Division of Pulmonary, Critical Care and Sleep Medicine
2021 – Current
·
University of Florida Department of Medicine – Jacksonville
Board Certifications
-
Critical Care MedicineAmerican Board of Internal Medicine
-
Geriatric MedicineAmerican Board of Internal Medicine
-
Internal MedicineAmerican Board of Internal Medicine
-
Pulmonary DiseaseAmerican Board of Internal Medicine
Clinical Profile
Dr. Mirsaeidi is a world renowned expert in the field of interstitial lung disease, sarcoidosis, lung cancer, and mycobacterial infections. He has been involved in numerous clinical studies and development of clinical guidelines.
Specialties
- General Internal Medicine
Subspecialties
- Critical Care Medicine
- Pulmonary Critical Care Medicine
- Pulmonary Disease
- Pulmonary Disease and Critical Care Medicine
Areas of Interest
- Coronavirus disease 2019 (COVID-19)
- Interstitial lung disease
- Lung Cancer
- Nontuberculous Mycobacteria
- Sarcoidosis
Research Profile
Open Researcher and Contributor ID (ORCID)
0000-0001-5298-8442
Areas of Interest
- Bacteriophage
- GHRHR
- Granulomata
- a-MSH
- bronchial epithelial cells
Publications
2024
Editorial: A year in review: discussions in pulmonary medicine.
Frontiers in medicine.
11
[DOI] 10.3389/fmed.2024.1434562.
[PMID] 38882663.
2024
Genome sequencing of Pseudomonas aeruginosa phages; UF_RH7 and UF_RH9
Microbiology Resource Announcements.
13(4)
[DOI] 10.1128/mra.01050-23.
[PMID] 38483455.
2024
Interstitial Lung Disease as an Emerging Contributor to Mortality in Patients With Inflammatory Bowel Disease: A Population-Based Epidemiological Study
Clinical and Translational Gastroenterology.
15(9)
[DOI] 10.14309/ctg.0000000000000720.
[PMID] 38822801.
2024
Phage therapy: breathing new tactics into lower respiratory tract infection treatments.
European respiratory review : an official journal of the European Respiratory Society.
33(172)
[DOI] 10.1183/16000617.0029-2024.
[PMID] 38925791.
2024
Proposing the potential of utilizing the CAT score for early detection of COPD in asymptomatic patients, shifting towards a patient-centered approach: A review
Medicine.
103(15)
[DOI] 10.1097/md.0000000000037715.
2024
Risk of 30-Day All-Cause Readmission in Interstitial Lung Disease Patients after COVID-19: National-Level Data
Annals of the American Thoracic Society.
21(3):428-437
[DOI] 10.1513/annalsats.202305-491oc.
2023
Acthar® Gel Treatment for Patients with Autoimmune and Inflammatory Diseases: An Historical Perspective and Characterization of Clinical Evidence.
Clinical drug investigation.
43(10):739-761
[DOI] 10.1007/s40261-023-01303-5.
[PMID] 37792273.
2023
Association of County-degree Social Vulnerability with Chronic Respiratory Disease Mortality in the United States
Annals of the American Thoracic Society.
20(1):47-57
[DOI] 10.1513/annalsats.202202-136oc.
2023
Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
27(10):729-741
[DOI] 10.5588/ijtld.23.0248.
[PMID] 37749839.
2023
Complete Genome Sequence of Pseudomonas aeruginosa Phage UF_RH6, Isolated from Human Lung
Microbiology Resource Announcements.
12(6)
[DOI] 10.1128/mra.00206-23.
[PMID] 37249420.
2023
Complete Genome Sequencing of a Novel Pseudomonas aeruginosa Phage, UF_RH5
Microbiology Resource Announcements.
12(7)
[DOI] 10.1128/mra.00396-23.
[PMID] 37338387.
2023
Complete Genome Sequencing of the Novel Pseudomonas aeruginosa Phage UF_RH1
Microbiology Resource Announcements.
12(6)
[DOI] 10.1128/mra.00139-23.
[PMID] 37166313.
2023
Impact of Global Climate Change on Pulmonary Health: Susceptible and Vulnerable Populations.
Annals of the American Thoracic Society.
20(8):1088-1095
[DOI] 10.1513/AnnalsATS.202212-996CME.
[PMID] 37126851.
2023
Management of nontuberculous mycobacteria in lung transplant cases: an international Delphi study.
ERJ open research.
9(2)
[DOI] 10.1183/23120541.00377-2022.
[PMID] 37009016.
2023
Management of Polydrug-Resistant Tuberculosis.
Medicina (Kaunas, Lithuania).
59(2)
[DOI] 10.3390/medicina59020246.
[PMID] 36837448.
2023
Predicting COVID-19 cases using SARS-CoV-2 RNA in air, surface swab and wastewater samples.
The Science of the total environment.
857(Pt 1)
[DOI] 10.1016/j.scitotenv.2022.159188.
[PMID] 36202365.
2023
Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis.
Pulmonary therapy.
9(2):237-253
[DOI] 10.1007/s41030-023-00222-2.
[PMID] 37072607.
2023
Role of anti-tumor necrosis factor-alpha agents in treatment of sarcoidosis: A meta-analysis
European Journal of Internal Medicine.
109:42-49
[DOI] 10.1016/j.ejim.2022.12.003.
2023
Sarcoidosis-associated pulmonary fibrosis: joining the dots.
European respiratory review : an official journal of the European Respiratory Society.
32(169)
[DOI] 10.1183/16000617.0085-2023.
[PMID] 37758275.
2022
Anti-inflammatory Properties of the Alpha-Melanocyte-Stimulating Hormone in Models of Granulomatous Inflammation.
Lung.
200(4):463-472
[DOI] 10.1007/s00408-022-00546-x.
[PMID] 35717488.
2022
Association of COVID-19 Case-Fatality Rate With State Health Disparity in the United States.
Frontiers in medicine.
9
[DOI] 10.3389/fmed.2022.853059.
[PMID] 35847787.
2022
Biochemical and genomic identification of novel biomarkers in progressive sarcoidosis: HBEGF, eNAMPT, and ANG-2.
Frontiers in medicine.
9
[DOI] 10.3389/fmed.2022.1012827.
[PMID] 36388923.
2022
COVID-19 and Acute Kidney Injury: A Systematic Review.
Frontiers in medicine.
9
[DOI] 10.3389/fmed.2022.705908.
[PMID] 35445048.
2022
COVID-19 in patients with and without acute kidney injury.
Bratislavske lekarske listy.
123(5):382-380
[DOI] 10.4149/BLL_2022_059.
[PMID] 35420885.
2022
COVID-19 Prediction using Genomic Footprint of SARS-CoV-2 in Air, Surface Swab and Wastewater Samples.
medRxiv : the preprint server for health sciences.
[DOI] 10.1101/2022.03.14.22272314.
[PMID] 35313580.
2022
Diagnostic Accuracy of Pyrazinamide Susceptibility Testing in Mycobacterium tuberculosis: A Systematic Review with Meta-Analysis.
Microbial drug resistance (Larchmont, N.Y.).
28(1):87-98
[DOI] 10.1089/mdr.2021.0048.
[PMID] 34582723.
2022
Diagnostic Accuracy of Rapid Antigen Tests for COVID-19 Detection: A Systematic Review With Meta-analysis.
Frontiers in medicine.
9
[DOI] 10.3389/fmed.2022.870738.
[PMID] 35463027.
2022
Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review.
Frontiers in cellular and infection microbiology.
12
[DOI] 10.3389/fcimb.2022.804644.
[PMID] 35310853.
2022
Editorial: Sarcoidosis-The great mimicker.
Frontiers in medicine.
9
[DOI] 10.3389/fmed.2022.990714.
[PMID] 35983097.
2022
Effect of Androgen Suppression on Clinical Outcomes in Hospitalized Men With COVID-19: The HITCH Randomized Clinical Trial.
JAMA network open.
5(4)
[DOI] 10.1001/jamanetworkopen.2022.7852.
[PMID] 35438754.
2022
Health effects of radioactive contaminated dust in the aftermath of potential nuclear accident in Ukraine.
Frontiers in public health.
10
[DOI] 10.3389/fpubh.2022.959668.
[PMID] 36072376.
2022
Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features
Molecular and Cellular Biochemistry.
477(3):711-726
[DOI] 10.1007/s11010-021-04325-9.
[PMID] 35013850.
2022
Pericardial Epithelioid Inflammatory Myofibroblastic Sarcoma: An Atypical Presentation.
Cureus.
14(7)
[DOI] 10.7759/cureus.26827.
[PMID] 35847167.
2022
Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review.
Pulmonary therapy.
8(1):43-55
[DOI] 10.1007/s41030-022-00181-0.
[PMID] 35113366.
2022
SARS-CoV-2 cell entry beyond the ACE2 receptor
Molecular Biology Reports.
49(11):10715-10727
[DOI] 10.1007/s11033-022-07700-x.
[PMID] 35754059.
2021
A Trend Analysis of Chronic Obstructive Pulmonary Disease Mortality in the United States by Race and Sex.
Annals of the American Thoracic Society.
18(7):1138-1146
[DOI] 10.1513/AnnalsATS.202007-822OC.
[PMID] 33347376.
2021
Activity of the growth hormone‐releasing hormone antagonist MIA602 and its underlying mechanisms of action in sarcoidosis‐like granuloma
Clinical & Translational Immunology.
10(7)
[DOI] 10.1002/cti2.1310.
[PMID] 34257968.
2021
Allergies, Allergic Comorbidities and the Home Environment in Pediatric Asthma in Southern Florida
International Journal of Environmental Research and Public Health.
18(8)
[DOI] 10.3390/ijerph18084142.
[PMID] 33919868.
2021
Antifibrotic and Anti-Inflammatory Actions of α-Melanocytic Hormone: New Roles for an Old Player
Pharmaceuticals.
14(1)
[DOI] 10.3390/ph14010045.
[PMID] 33430064.
2021
Associations of Yersinia Enterocolitica Infection with Autoimmune Thyroid Diseases: A Systematic Review and Meta-Analysis.
Endocrine, metabolic & immune disorders drug targets.
21(4):682-687
[DOI] 10.2174/1871530320666200621180515.
[PMID] 32564766.
2021
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths.
Science immunology.
6(62)
[DOI] 10.1126/sciimmunol.abl4340.
[PMID] 34413139.
2021
Clofazimine susceptibility testing of Mycobacterium avium complex and Mycobacterium abscessus: a meta-analysis study.
Journal of global antimicrobial resistance.
26:188-193
[DOI] 10.1016/j.jgar.2021.06.002.
[PMID] 34153525.
2021
Commentary: Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2.
Frontiers in medicine.
8
[DOI] 10.3389/fmed.2021.747109.
[PMID] 34631759.
2021
Comparison of Rifabutin-Based Versus Rifampin-Based Regimens for the Treatment of Mycobacterium avium Complex: A meta-Analysis Study.
Frontiers in pharmacology.
12
[DOI] 10.3389/fphar.2021.693369.
[PMID] 34557091.
2021
COVID-19 and Cardiomyopathy: A Systematic Review.
Frontiers in cardiovascular medicine.
8
[DOI] 10.3389/fcvm.2021.695206.
[PMID] 34222385.
2021
COVID-19 and cause of pregnancy loss during the pandemic: A systematic review.
PloS one.
16(8)
[DOI] 10.1371/journal.pone.0255994.
[PMID] 34379700.
2021
Distinct Mucoinflammatory Phenotype and the Immunomodulatory Long Noncoding Transcripts Associated with SARS-CoV-2 Airway Infection.
medRxiv : the preprint server for health sciences.
[DOI] 10.1101/2021.05.13.21257152.
[PMID] 34031668.
2021
Drug-Induced Liver Injury in COVID-19 Patients: A Systematic Review.
Frontiers in medicine.
8
[DOI] 10.3389/fmed.2021.731436.
[PMID] 34616757.
2021
Effect of Face Masks on Gas Exchange in Healthy Persons and Patients with Chronic Obstructive Pulmonary Disease.
Annals of the American Thoracic Society.
18(3):541-544
[DOI] 10.1513/AnnalsATS.202007-812RL.
[PMID] 33003954.
2021
Inborn Errors in the LRR Domain of Nod2 and Their Potential Consequences on the Function of the Receptor
Cells.
10(8)
[DOI] 10.3390/cells10082031.
[PMID] 34440800.
2021
Long‐term exposure to indoor air pollution and risk of tuberculosis
Indoor Air.
31(3):628-638
[DOI] 10.1111/ina.12756.
[PMID] 33016379.
2021
Machine-learning-based COVID-19 mortality prediction model and identification of patients at low and high risk of dying
Critical Care.
25(1)
[DOI] 10.1186/s13054-021-03749-5.
[PMID] 34496940.
2021
Mask-off policy in the shadow of emerging variants of SARS-COV-2
European Journal of Internal Medicine.
90:109-110
[DOI] 10.1016/j.ejim.2021.06.015.
[PMID] 34193373.
2021
Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): diagnosis, treatment, therapy and future perspectives.
Nanomedicine (London, England).
16(6):497-516
[DOI] 10.2217/nnm-2020-0441.
[PMID] 33683164.
2021
Nontuberculous Mycobacteria, Macrophages, and Host Innate Immune Response
Infection and Immunity.
89(8)
[DOI] 10.1128/iai.00812-20.
2021
Novel three-dimensional biochip pulmonary sarcoidosis model
PLOS ONE.
16(2)
[DOI] 10.1371/journal.pone.0245805.
[PMID] 33539409.
2021
Performance of Wayne assay for detection of pyrazinamide resistance in Mycobacterium tuberculosis: a meta-analysis study.
New microbes and new infections.
42
[DOI] 10.1016/j.nmni.2021.100886.
[PMID] 34141437.
2021
Perspectives on the Health Effects of Hurricanes: A Review and Challenges
International Journal of Environmental Research and Public Health.
18(5)
[DOI] 10.3390/ijerph18052756.
[PMID] 33803162.
2021
Phage Therapy for Mycobacterium Abscessus and Strategies to Improve Outcomes
Microorganisms.
9(3)
[DOI] 10.3390/microorganisms9030596.
[PMID] 33799414.
2021
Pulmonary nontuberculous mycobacterial disease in Florida and association with large-scale natural disasters
BMC Public Health.
21(1)
[DOI] 10.1186/s12889-021-12115-7.
[PMID] 34758787.
2021
Role of Clofazimine in Treatment of Mycobacterium avium Complex.
Frontiers in medicine.
8
[DOI] 10.3389/fmed.2021.638306.
[PMID] 33968952.
2021
Role of IgG against N-protein of SARS-CoV2 in COVID19 clinical outcomes.
Scientific reports.
11(1)
[DOI] 10.1038/s41598-021-83108-0.
[PMID] 33568776.
2021
Sarcoidosis or cancer? That is the question.
Respiratory medicine case reports.
33
[DOI] 10.1016/j.rmcr.2021.101426.
[PMID] 34401272.
2021
Skin Manifestations in COVID-19 Patients: Are They Indicators for Disease Severity? A Systematic Review.
Frontiers in medicine.
8
[DOI] 10.3389/fmed.2021.634208.
[PMID] 33665200.
2021
State-Level Health Disparity Is Associated with Sarcoidosis Mortality
Journal of Clinical Medicine.
10(11)
[DOI] 10.3390/jcm10112366.
[PMID] 34072248.
2021
Structural Analysis of the Novel Variants of SARS-CoV-2 and Forecasting in North America.
Viruses.
13(5)
[DOI] 10.3390/v13050930.
[PMID] 34067890.
2021
The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review.
Frontiers in endocrinology.
12
[DOI] 10.3389/fendo.2021.645194.
[PMID] 33815295.
2021
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.
Science immunology.
6(62)
[DOI] 10.1126/sciimmunol.abl4348.
[PMID] 34413140.
2020
<p>Ocular Manifestations of Sarcoidosis in a South Florida Population</p>
Clinical Ophthalmology.
Volume 14:3741-3746
[DOI] 10.2147/opth.s278373.
2020
Anti-inflammatory effects of α-MSH through p-CREB expression in sarcoidosis like granuloma model
Scientific Reports.
10(1)
[DOI] 10.1038/s41598-020-64305-9.
[PMID] 32350353.
2020
Antibiotic therapy success rate in pulmonary Mycobacterium avium complex: a systematic review and meta-analysis.
Expert review of anti-infective therapy.
18(3):263-273
[DOI] 10.1080/14787210.2020.1720650.
[PMID] 31986933.
2020
Association between African Dust Transport and Acute Exacerbations of COPD in Miami
Journal of Clinical Medicine.
9(8)
[DOI] 10.3390/jcm9082496.
[PMID] 32756441.
2020
Association of Serum Albumin and Severity of Pulmonary Embolism.
Medicina (Kaunas, Lithuania).
56(1)
[DOI] 10.3390/medicina56010026.
[PMID] 31936687.
2020
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.
Science (New York, N.Y.).
370(6515)
[DOI] 10.1126/science.abd4585.
[PMID] 32972996.
2020
Case Series: COVID-19 in African American Patients With Sarcoidosis.
Frontiers in medicine.
7
[DOI] 10.3389/fmed.2020.588527.
[PMID] 33251236.
2020
Clinical Features, Diagnosis, and Treatment of COVID-19 in Hospitalized Patients: A Systematic Review of Case Reports and Case Series.
Frontiers in medicine.
7
[DOI] 10.3389/fmed.2020.00231.
[PMID] 32574328.
2020
COVID-19 Clinical Characteristics, and Sex-Specific Risk of Mortality: Systematic Review and Meta-Analysis.
Frontiers in medicine.
7
[DOI] 10.3389/fmed.2020.00459.
[PMID] 32793620.
2020
COVID-19: Risk of alcohol abuse and psychiatric disorders.
Respiratory medicine case reports.
31
[DOI] 10.1016/j.rmcr.2020.101222.
[PMID] 32953449.
2020
Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis.
European respiratory review : an official journal of the European Respiratory Society.
29(155)
[DOI] 10.1183/16000617.0146-2019.
[PMID] 32198218.
2020
Diagnostic Accuracy of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) in Real Life.
Frontiers in medicine.
7
[DOI] 10.3389/fmed.2020.00118.
[PMID] 32318581.
2020
Editorial: Interstitial Lung Disease in the Context of Systemic Disease: Pathophysiology, Treatment and Outcomes.
Frontiers in medicine.
7
[DOI] 10.3389/fmed.2020.644075.
[PMID] 33585522.
2020
Effects of 100 % oxygen during exercise in patients with interstitial lung disease.
Respiratory physiology & neurobiology.
274
[DOI] 10.1016/j.resp.2019.103367.
[PMID] 31911201.
2020
Genotyping and drug susceptibility testing of Mycobacterium tuberculosis in Iran: a multi-centre study.
New microbes and new infections.
37
[DOI] 10.1016/j.nmni.2020.100729.
[PMID] 32774869.
2020
Growth Hormone-Releasing Hormone in Lung Physiology and Pulmonary Disease
Cells.
9(10)
[DOI] 10.3390/cells9102331.
[PMID] 33096674.
2020
Health and Economy in COVID-19 Era: A Plan for Reconstituting Long-Term Economic Security.
Frontiers in public health.
8
[DOI] 10.3389/fpubh.2020.00235.
[PMID] 32574304.
2020
Improving survival outcome among elderly lung transplant recipients.
European journal of internal medicine.
74:121-124
[DOI] 10.1016/j.ejim.2020.01.012.
[PMID] 32001096.
2020
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.
Science (New York, N.Y.).
370(6515)
[DOI] 10.1126/science.abd4570.
[PMID] 32972995.
2020
Lack of tocilizumab effect on mortality in COVID19 patients
Scientific Reports.
10(1)
[DOI] 10.1038/s41598-020-74328-x.
[PMID] 33051534.
2020
Management of crash and burn patients with SARS-CoV-2 associated ARDS.
Journal of cardiac surgery.
35(9):2129-2130
[DOI] 10.1111/jocs.14699.
[PMID] 32663349.
2020
Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study.
European respiratory review : an official journal of the European Respiratory Society.
29(155)
[DOI] 10.1183/16000617.0147-2019.
[PMID] 32198219.
2020
Missense (p.Glu778Lys) and (p.Gly908Arg) variants of NOD2 gene are associated with recurrent pulmonary non‐tuberculous mycobacterial infections
Scandinavian Journal of Immunology.
92(3)
[DOI] 10.1111/sji.12935.
2020
Olfactory and gustatory dysfunction in COVID‐19 patients: A meta‐analysis study
Physiological Reports.
8(18)
[DOI] 10.14814/phy2.14578.
[PMID] 32975884.
2020
Potential Mechanisms for COVID-19 Induced Anosmia and Dysgeusia.
Frontiers in physiology.
11
[DOI] 10.3389/fphys.2020.01039.
[PMID] 33041842.
2020
Presence of concurrent sarcoid-like granulomas indicates better survival in cancer patients: a retrospective cohort study.
ERJ open research.
6(4)
[DOI] 10.1183/23120541.00061-2020.
[PMID] 33263026.
2020
Prevalence and Mechanisms of Carbapenem Resistance in Klebsiella pneumoniae and Escherichia coli: A Systematic Review and Meta-Analysis of Cross-Sectional Studies from Iran.
Microbial drug resistance (Larchmont, N.Y.).
26(12):1491-1502
[DOI] 10.1089/mdr.2019.0440.
[PMID] 32348701.
2020
Protective effect of influenza vaccination on cardiovascular diseases: a systematic review and meta-analysis.
Scientific reports.
10(1)
[DOI] 10.1038/s41598-020-77679-7.
[PMID] 33244069.
2020
STAT3 gain-of-function mutation in a patient with pulmonary Mycobacterium abscessus infection.
Respiratory medicine case reports.
30
[DOI] 10.1016/j.rmcr.2020.101125.
[PMID] 32577366.
2020
State-Level Disparity in Lung Cancer Survival in the United States.
Frontiers in oncology.
10
[DOI] 10.3389/fonc.2020.01449.
[PMID] 32974167.
2020
The COVID-19 Pandemic-Can open access modeling give us better answers more quickly?
Journal of applied clinical medical physics.
21(6):4-6
[DOI] 10.1002/acm2.12941.
[PMID] 32476231.
2019
An update on IgG4-related lung disease.
European journal of internal medicine.
66:18-24
[DOI] 10.1016/j.ejim.2019.06.010.
[PMID] 31227290.
2019
Electronic Cigarettes Enhance Replication of Mycobacterium abscessus in Airway Epithelial Cells
American Journal of Respiratory Cell and Molecular Biology.
60(6):717-719
[DOI] 10.1165/rcmb.2018-0339le.
2019
Growth Hormone-Releasing Hormone Receptor Antagonist Modulates Lung Inflammation and Fibrosis due to Bleomycin.
Lung.
197(5):541-549
[DOI] 10.1007/s00408-019-00257-w.
[PMID] 31392398.
2019
Guidelines-based treatment associated with improved economic outcomes in nontuberculous mycobacterial lung disease.
Journal of medical economics.
22(11):1126-1133
[DOI] 10.1080/13696998.2019.1620243.
[PMID] 31094592.
2019
Hepatic Sarcoidosis: Natural History and Management Implications.
Frontiers in medicine.
6
[DOI] 10.3389/fmed.2019.00232.
[PMID] 31737633.
2019
Low diagnostic accuracy of Xpert MTB/RIF assay for extrapulmonary tuberculosis: A multicenter surveillance
Scientific Reports.
9(1)
[DOI] 10.1038/s41598-019-55112-y.
[PMID] 31811239.
2019
Metabolomic and metallomic profile differences between Veterans and Civilians with Pulmonary Sarcoidosis
Scientific Reports.
9(1)
[DOI] 10.1038/s41598-019-56174-8.
[PMID] 31863066.
2019
Mycobacterium abscessus-Bronchial Epithelial Cells Cross-Talk Through Type I Interferon Signaling.
Frontiers in immunology.
10
[DOI] 10.3389/fimmu.2019.02888.
[PMID] 31921151.
2019
Mycobacterium avium complex infection in patients with human immunodeficiency virus: A systematic review and meta-analysis.
Journal of cellular physiology.
234(7):9994-10001
[DOI] 10.1002/jcp.27859.
[PMID] 30548598.
2019
Rescue therapy for hypercapnia due to high PEEP mechanical ventilation in patients with ARDS and renal failure.
Artificial organs.
43(6):599-604
[DOI] 10.1111/aor.13393.
[PMID] 30431163.
2019
Serum Albumin as a Biomarker of Pulmonary Sarcoidosis Chronicity.
Turkish thoracic journal.
20(4):236-240
[DOI] 10.5152/TurkThoracJ.2018.094.
[PMID] 31584385.
2019
Systemic Sclerosis Associated Interstitial Lung Disease: New Directions in Disease Management.
Frontiers in medicine.
6
[DOI] 10.3389/fmed.2019.00248.
[PMID] 31737640.
2019
The Importance of Melanocortin Receptors and Their Agonists in Pulmonary Disease.
Frontiers in medicine.
6
[DOI] 10.3389/fmed.2019.00145.
[PMID] 31316990.
2019
The unexplained increase of nontuberculous mycobacteriosis.
International journal of mycobacteriology.
8(1):1-6
[DOI] 10.4103/ijmy.ijmy_18_19.
[PMID] 30860172.
2018
A portrait of patients who die in-hospital from acute pulmonary embolism.
The American journal of emergency medicine.
36(10):1914-1916
[DOI] 10.1016/j.ajem.2018.02.035.
[PMID] 29525476.
2018
A Young Woman with Bradycardia and Hypotension
Annals of the American Thoracic Society.
15(9):1092-1095
[DOI] 10.1513/annalsats.201802-142cc.
2018
Circulatory TGF-beta1 is significantly higher in early stage of pulmonary sarcoidosis.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
35(3):213-217
[DOI] 10.36141/svdld.v35i3.6112.
[PMID] 32476905.
2018
Diagnosis of nontuberculous mycobacterial disease in the era of surveillance chest CT scans
Infection.
46(6):861-865
[DOI] 10.1007/s15010-018-1232-3.
2018
Differences in vaping topography in relation to adherence to exclusive electronic cigarette use in veterans.
PloS one.
13(4)
[DOI] 10.1371/journal.pone.0195896.
[PMID] 29694428.
2018
Health Care Utilization and Expenditures Following Diagnosis of Nontuberculous Mycobacterial Lung Disease in the United States.
Journal of managed care & specialty pharmacy.
24(10):964-974
[DOI] 10.18553/jmcp.2018.18122.
[PMID] 30028225.
2018
Hypoalbuminemia is related to inflammation rather than malnutrition in sarcoidosis.
European journal of internal medicine.
53:e14-e16
[DOI] 10.1016/j.ejim.2018.04.016.
[PMID] 29703691.
2018
Impact of seasonal variation in meteorological conditions on dry eye severity
Clinical Ophthalmology.
Volume 12:2471-2481
[DOI] 10.2147/opth.s181637.
2018
Increasing Non-tuberculous Mycobacteria Infections in Veterans With COPD and Association With Increased Risk of Mortality.
Frontiers in medicine.
5
[DOI] 10.3389/fmed.2018.00311.
[PMID] 30460238.
2018
Lung health in era of climate change and dust storms.
Environmental research.
163:36-42
[DOI] 10.1016/j.envres.2018.02.001.
[PMID] 29426026.
2018
Mycobacterium ahvazicum sp. nov., the nineteenth species of the Mycobacterium simiae complex
Scientific Reports.
8(1)
[DOI] 10.1038/s41598-018-22526-z.
[PMID] 29515197.
2018
Mycobacterium avium Complex Extracellular Vesicles Attenuate Inflammation via Inducing IL-10.
International journal of molecular and cellular medicine.
7(4):241-250
[DOI] 10.22088/IJMCM.BUMS.7.4.241.
[PMID] 31516884.
2018
Noncoding RNAs: New Players in Pulmonary Medicine and Sarcoidosis
American Journal of Respiratory Cell and Molecular Biology.
58(2):147-156
[DOI] 10.1165/rcmb.2017-0196tr.
2018
Patients at high risk of tuberculosis recurrence.
International journal of mycobacteriology.
7(1):1-6
[DOI] 10.4103/ijmy.ijmy_164_17.
[PMID] 29516879.
2018
Prevalence of nontuberculous mycobacteria and high efficacy of d-cycloserine and its synergistic effect with clarithromycin against Mycobacterium fortuitum and Mycobacterium abscessus.
Infection and drug resistance.
11:2521-2532
[DOI] 10.2147/IDR.S187554.
[PMID] 30573983.
2018
rpoB gene mutations among Mycobacterium tuberculosis isolates from extrapulmonary sites.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
126(3):241-247
[DOI] 10.1111/apm.12804.
[PMID] 29484749.
2018
Syncope on presentation is a surrogate for submassive and massive acute pulmonary embolism.
The American journal of emergency medicine.
36(2):297-300
[DOI] 10.1016/j.ajem.2017.11.014.
[PMID] 29146419.
2018
The Italian registry of pulmonary non-tuberculous mycobacteria – IRENE: the study protocol.
Multidisciplinary respiratory medicine.
13(Suppl 1)
[DOI] 10.1186/s40248-018-0141-8.
[PMID] 30151192.
2018
The low prevalence of pulmonary embolism in patients with syncope: What should clinicians do?
The American journal of emergency medicine.
36(10):1917-1918
[DOI] 10.1016/j.ajem.2018.02.037.
[PMID] 29514749.
2018
What Immunological Defects Predispose to Non-tuberculosis Mycobacterial Infections?
Iranian journal of allergy, asthma, and immunology.
17(2):100-109
[PMID] 29757583.
2018
White donor, younger donor and double lung transplant are associated with better survival in sarcoidosis patients
Scientific Reports.
8(1)
[DOI] 10.1038/s41598-018-25144-x.
[PMID] 29725035.
2017
A Patient-Based Analysis of the Geographic Distribution of Mycobacterium avium complex, Mycobacterium abscessus, and Mycobacterium kansasii Infections in the United States.
Chest.
151(4):947-950
[DOI] 10.1016/j.chest.2017.02.013.
[PMID] 28390637.
2017
A risky political game with climate change.
The European respiratory journal.
50(4)
[DOI] 10.1183/13993003.01145-2017.
[PMID] 28982778.
2017
Body habitus in patients with and without bronchiectasis and non-tuberculous mycobacteria
PLOS ONE.
12(9)
[DOI] 10.1371/journal.pone.0185095.
[PMID] 28957340.
2017
Bovis Bacillus Calmette-Guerin (BCG) infection induces exosomal miRNA release by human macrophages.
Journal of translational medicine.
15(1)
[DOI] 10.1186/s12967-017-1205-9.
[PMID] 28499455.
2017
Cardiovascular complications and mortality determinants in near drowning victims: A 5-year retrospective analysis.
Journal of critical care.
37:237-239
[DOI] 10.1016/j.jcrc.2016.09.010.
[PMID] 27692797.
2017
Improving adherence to alpha-1 antitrypsin deficiency screening guidelines using the pulmonary function laboratory.
International journal of chronic obstructive pulmonary disease.
12:2257-2259
[DOI] 10.2147/COPD.S143424.
[PMID] 28814853.
2017
Mixed infections in tuberculosis: The missing part in a puzzle.
Tuberculosis (Edinburgh, Scotland).
107:168-174
[DOI] 10.1016/j.tube.2017.09.004.
[PMID] 29050766.
2017
Mycobacterium aquaticum sp. nov., a rapidly growing species isolated from haemodialysis water.
International journal of systematic and evolutionary microbiology.
67(9):3279-3282
[DOI] 10.1099/ijsem.0.002103.
[PMID] 28829035.
2017
Mycobacterium persicum sp. nov., a novel species closely related to Mycobacterium kansasii and Mycobacterium gastri.
International journal of systematic and evolutionary microbiology.
67(6):1766-1770
[DOI] 10.1099/ijsem.0.001862.
[PMID] 28629501.
2017
Recurrent Drug-Induced Hepatitis in Tuberculosis-Comparison of Two Drug Regimens.
American journal of therapeutics.
24(2):e144-e149
[DOI] 10.1097/MJT.0000000000000218.
[PMID] 26057141.
2017
Sarcoidosis onset after breast cancer; a potential association
European Journal of Internal Medicine.
44:e11-e12
[DOI] 10.1016/j.ejim.2017.08.006.
2017
Toll-like receptors in mycobacterial infection.
European journal of pharmacology.
808:1-7
[DOI] 10.1016/j.ejphar.2016.10.018.
[PMID] 27756604.
2016
Annexin A11 is associated with pulmonary fibrosis in African American patients with sarcoidosis.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
33(4):418-422
[PMID] 28079857.
2016
Annexins family: insights into their functions and potential role in pathogenesis of sarcoidosis.
Journal of translational medicine.
14
[DOI] 10.1186/s12967-016-0843-7.
[PMID] 27071553.
2016
Association of Neutrophil to Lymphocyte Ratio and Pulmonary Hypertension in Sarcoidosis Patients.
Tanaffos.
15(1):44-7
[PMID] 27403178.
2016
Climate Change and Respiratory Infections
Annals of the American Thoracic Society.
13(8):1223-1230
[DOI] 10.1513/annalsats.201511-729ps.
2016
Duration of ECMO Is an Independent Predictor of Intracranial Hemorrhage Occurring During ECMO Support.
ASAIO journal (American Society for Artificial Internal Organs : 1992).
62(5):634-6
[DOI] 10.1097/MAT.0000000000000368.
[PMID] 26978708.
2016
Exosomes and Exosomal miRNA in Respiratory Diseases
Mediators of Inflammation.
2016:1-11
[DOI] 10.1155/2016/5628404.
[PMID] 27738390.
2016
Haarlem 3 is the predominant genotype family in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in the capital of Iran: A 5-year survey.
Journal of global antimicrobial resistance.
5:7-10
[DOI] 10.1016/j.jgar.2016.01.007.
[PMID] 27436458.
2016
High prevalence of Mycobacterium tuberculosis mixed infection in the capital of moderate tuberculosis incidence country.
Microbial pathogenesis.
93:213-8
[DOI] 10.1016/j.micpath.2016.02.015.
[PMID] 26944666.
2016
In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
Microbial drug resistance (Larchmont, N.Y.).
22(2):172-8
[DOI] 10.1089/mdr.2015.0134.
[PMID] 26468990.
2016
Incidence and predictors of ischemic cerebrovascular stroke among patients on extracorporeal membrane oxygenation support
Journal of Critical Care.
32:48-51
[DOI] 10.1016/j.jcrc.2015.11.009.
2016
Management of extrapulmonary sarcoidosis: challenges and solutions.
Therapeutics and clinical risk management.
12:1623-1634
[PMID] 27853374.
2016
Microbiological Analysis of Hemodialysis Water in a Developing Country.
ASAIO journal (American Society for Artificial Internal Organs : 1992).
62(3):332-9
[DOI] 10.1097/MAT.0000000000000353.
[PMID] 26919181.
2016
Plasma metabolomic profile in fibrosing pulmonary sarcoidosis.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
33(1):29-38
[PMID] 27055833.
2016
Reply: Metabolomics and Mycobacterial Disease: Don’t Forget the Bioinformatics
Annals of the American Thoracic Society.
13(1):142-143
[DOI] 10.1513/annalsats.201510-711le.
2016
The association between BNP, 6MWD test, DLCO% and pulmonary hypertension in sarcoidosis.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
33(4):317-320
[PMID] 28079843.
2016
The Association between ESR and CRP and Systemic Hypertension in Sarcoidosis.
International journal of hypertension.
2016
[DOI] 10.1155/2016/2402515.
[PMID] 27433355.
2016
The roles of miRNAs as potential biomarkers in lung diseases.
European journal of pharmacology.
791:395-404
[DOI] 10.1016/j.ejphar.2016.09.015.
[PMID] 27634639.
2016
The simultaneous recording of right- and left-sided electrocardiogram in acute pulmonary embolism.
The American journal of emergency medicine.
34(6):1183.e5-7
[DOI] 10.1016/j.ajem.2015.11.018.
[PMID] 26643161.
2015
Association of serum TNF-α, IL-8 and free light chain with HLA-DR B alleles expression in pulmonary and extra-pulmonary sarcoidosis.
Journal of inflammation (London, England).
12
[DOI] 10.1186/s12950-015-0066-3.
[PMID] 25866481.
2015
Gender susceptibility to mycobacterial infections in patients with non-CF bronchiectasis
International Journal of Mycobacteriology.
4(2):92-96
[DOI] 10.1016/j.ijmyco.2015.05.002.
[PMID] 26097805.
2015
Genetic diversity and antimicrobial susceptibility of Nocardia species among patients with nocardiosis.
Scientific reports.
5
[DOI] 10.1038/srep17862.
[PMID] 26638771.
2015
Hospital costs in the US for pulmonary mycobacterial diseases
International Journal of Mycobacteriology.
4(3):217-221
[DOI] 10.1016/j.ijmyco.2015.05.003.
[PMID] 26258029.
2015
Identification and genotyping of Mycobacterium tuberculosis isolated from water and soil samples of a metropolitan city.
Chest.
147(4):1094-1102
[DOI] 10.1378/chest.14-0960.
[PMID] 25340935.
2015
Metabolomics: Applications and Promise in Mycobacterial Disease
Annals of the American Thoracic Society.
12(9):1278-1287
[DOI] 10.1513/annalsats.201505-279ps.
2015
Nontuberculous mycobacteria in Middle East: Current situation and future challenges
International Journal of Mycobacteriology.
4(1):7-17
[DOI] 10.1016/j.ijmyco.2014.12.005.
2015
Nontuberculous Mycobacteria Isolation from Clinical and Environmental Samples in Iran: Twenty Years of Surveillance
BioMed Research International.
2015:1-10
[DOI] 10.1155/2015/254285.
[PMID] 26180788.
2015
Nontuberculous Mycobacteria: Epidemiologic, Mycobacteriologic, and Clinical Aspects
BioMed Research International.
2015:1-2
[DOI] 10.1155/2015/523697.
[PMID] 26161405.
2015
Plasma Free Hemoglobin Is an Independent Predictor of Mortality among Patients on Extracorporeal Membrane Oxygenation Support.
PloS one.
10(4)
[DOI] 10.1371/journal.pone.0124034.
[PMID] 25902047.
2015
Primary sclerosing cholangitis in common variable immune deficiency.
Allergology international : official journal of the Japanese Society of Allergology.
64(2):187-9
[DOI] 10.1016/j.alit.2014.09.003.
[PMID] 25838096.
2015
Racial difference in sarcoidosis mortality in the United States.
Chest.
147(2):438-449
[DOI] 10.1378/chest.14-1120.
[PMID] 25188873.
2015
Response.
Chest.
147(2):e65-e66
[DOI] 10.1378/chest.14-2603.
[PMID] 25644926.
2015
Response.
Chest.
147(4):e158-e159
[DOI] 10.1378/chest.14-3235.
[PMID] 25846544.
2015
Sarcoidosis in the National Veteran Population
Ophthalmology.
122(5):934-938
[DOI] 10.1016/j.ophtha.2015.01.003.
[PMID] 25687027.
2015
Towards personalized medicine in mycobacterial diseases; from bench to bedside
International Journal of Mycobacteriology.
4
[DOI] 10.1016/j.ijmyco.2014.08.005.
2015
Video directly observed therapy for treatment of tuberculosis is patient-oriented and cost-effective.
The European respiratory journal.
46(3):871-4
[DOI] 10.1183/09031936.00011015.
[PMID] 25792632.
2015
“Multidrug-resistant tuberculosis” may be nontuberculous mycobacteria
European Journal of Internal Medicine.
26(4):279-284
[DOI] 10.1016/j.ejim.2015.03.001.
[PMID] 25784643.
2014
Adalimumab Induced Subcutaneous Nodular Sarcoidosis; A Rare Side Effect of Tumor Necrosis Factor-α Inhibitor.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
31(3):249-51
[PMID] 25363227.
2014
Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
31(1):46-54
[PMID] 24751453.
2014
Highlight on advances in nontuberculous mycobacterial disease in North America.
BioMed research international.
2014
[DOI] 10.1155/2014/919474.
[PMID] 25574470.
2014
Management of nontuberculous mycobacterial infection in the elderly
European Journal of Internal Medicine.
25(4):356-363
[DOI] 10.1016/j.ejim.2014.03.008.
[PMID] 24685313.
2014
Molecular epidemiology of nontuberculous mycobacteria isolates from clinical and environmental sources of a metropolitan city.
PloS one.
9(12)
[DOI] 10.1371/journal.pone.0114428.
[PMID] 25485795.
2014
Nontuberculous mycobacterial disease mortality in the United States, 1999-2010: a population-based comparative study.
PloS one.
9(3)
[DOI] 10.1371/journal.pone.0091879.
[PMID] 24632814.
2014
Pneumococcal Vaccine and Patients with Pulmonary Diseases
The American Journal of Medicine.
127(9):886.e1-886.e8
[DOI] 10.1016/j.amjmed.2014.05.010.
[PMID] 24852934.
2014
Pneumococcal vaccines: understanding centers for disease control and prevention recommendations.
Annals of the American Thoracic Society.
11(6):980-5
[DOI] 10.1513/AnnalsATS.201401-042CME.
[PMID] 25032872.
2014
Rifampin induced angioedema: a rare but serious side effect.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
18(1):102-3
[DOI] 10.1016/j.bjid.2013.08.001.
[PMID] 24275373.
2014
Rituximab in the treatment of refractory pulmonary sarcoidosis.
The European respiratory journal.
43(5):1525-8
[DOI] 10.1183/09031936.00224513.
[PMID] 24488568.
2014
The role of vaccination in preventing pneumococcal disease in adults.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
20 Suppl 5(0 5):52-8
[DOI] 10.1111/1469-0691.12518.
[PMID] 24410778.
2013
After 40 years, new medicine for combating TB.
International journal of mycobacteriology.
2(1):1-2
[PMID] 25045621.
2013
Antineutrophil Cytoplasmic Autoantibody Associated Systemic Vasculitis Is Associated with Epstein – Barr virus in the Setting of HIV Infection.
Infectious diseases in clinical practice (Baltimore, Md.).
21(1):50-53
[PMID] 23483275.
2013
Multidrug-resistant tuberculosis treatment with linezolid-containing regimen.
International journal of mycobacteriology.
2(4):233-236
[PMID] 25110635.
2013
Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
17(11):e1000-4
[DOI] 10.1016/j.ijid.2013.03.018.
[PMID] 23683809.
2013
Nonsteroidal therapy of sarcoidosis.
Current opinion in pulmonary medicine.
19(5):516-23
[DOI] 10.1097/MCP.0b013e3283642ad0.
[PMID] 23884295.
2013
Outcomes in females hospitalised with community-acquired pneumonia are worse than in males.
The European respiratory journal.
41(5):1135-40
[DOI] 10.1183/09031936.00046212.
[PMID] 22835618.
2012
Personalized medicine approach in mycobacterial disease.
International journal of mycobacteriology.
1(2):59-64
[PMID] 25126491.
2012
Rifapentine and isoniazid for latent tuberculosis.
The New England journal of medicine.
366(15):1447-8
[DOI] 10.1056/NEJMc1200489.
[PMID] 22494128.
2011
Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia.
Chest.
140(2):482-488
[DOI] 10.1378/chest.10-2895.
[PMID] 21330383.
2011
Generalized lymphadenopathy with cystic spleen lesions: a rare presentation of tuberculosis.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
15(7)
[DOI] 10.1016/j.ijid.2011.03.010.
[PMID] 21555230.
2011
Utility of Gastric Lavage for Diagnosis of Tuberculosis in Patients who are Unable to Expectorate Sputum.
Journal of global infectious diseases.
3(4):339-43
[DOI] 10.4103/0974-777X.91054.
[PMID] 22223995.
2010
Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia.
Chest.
137(2):416-20
[DOI] 10.1378/chest.09-0998.
[PMID] 19837825.
2010
Vitamin D receptor homozygote mutant tt and bb are associated with susceptibility to pulmonary tuberculosis in the Iranian population.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
14(1):e84-5
[DOI] 10.1016/j.ijid.2009.05.001.
[PMID] 19482503.
2009
Comparison of the effectiveness of 2 treatment regimens in patients with isoniazid-resistant tuberculosis.
Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.
15(6):1346-50
[PMID] 20218123.
2009
First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran–eight years of surveillance.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
13(5):e236-40
[DOI] 10.1016/j.ijid.2008.11.027.
[PMID] 19285897.
2009
Is standardized treatment appropriate for non-XDR multiple drug resistant tuberculosis cases? A clinical descriptive study.
Scandinavian journal of infectious diseases.
41(1):10-3
[DOI] 10.1080/00365540802298079.
[PMID] 19037820.
2009
Nontuberculous mycobacteria among patients who are suspected for multidrug-resistant tuberculosis-need for earlier identification of nontuberculosis mycobacteria.
The American journal of the medical sciences.
337(3):182-4
[PMID] 19301453.
2009
Predicting mortality in patients with ventilator-associated pneumonia: The APACHE II score versus the new IBMP-10 score.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
49(1):72-7
[DOI] 10.1086/599349.
[PMID] 19480582.
2009
The NRAMPI, VDR and TNF-alpha gene polymorphisms in Iranian tuberculosis patients: the study on host susceptibility.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
13(4):252-6
[PMID] 20231985.
2008
Acute myocardial infarction in hospitalized patients with community-acquired pneumonia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
47(2):182-7
[DOI] 10.1086/589246.
[PMID] 18533841.
2008
Inappropriate use of steroid and pneumocystis jiroveci pneumonia: report of two cases.
Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.
14(5):1217-21
[PMID] 19161096.
2008
Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia.
Chest.
134(5):955-962
[DOI] 10.1378/chest.08-0334.
[PMID] 18583514.
2008
Outcome of treatment of MDR-TB patients with standardised regimens, Iran, 2002-2006.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
12(7):750-5
[PMID] 18544199.
2008
Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in Iran.
Respirology (Carlton, Vic.).
13(1):108-11
[DOI] 10.1111/j.1440-1843.2007.01201.x.
[PMID] 18197919.
2008
The recent-transmission of Mycobacterium tuberculosis strains among Iranian and Afghan relapse cases: a DNA-fingerprinting using RFLP and spoligotyping.
BMC infectious diseases.
8
[DOI] 10.1186/1471-2334-8-109.
[PMID] 18681980.
2008
Treatment outcome of tuberculosis patients diagnosed with human immunodeficiency virus infection in Iran.
Saudi medical journal.
29(1):148-50
[PMID] 18176695.
2007
Adverse reactions of anti-tuberculosis drugs in hospitalized patients: incidence, severity and risk factors.
Pharmacoepidemiology and drug safety.
16(10):1104-10
[PMID] 17823987.
2007
Differences in characteristics between Afghani and Iranian patients with pulmonary tuberculosis.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
11(2):180-2
[PMID] 16859946.
2007
Do mitochondrial DNA haplogroups play a role in susceptibility to tuberculosis?
Respirology (Carlton, Vic.).
12(6):823-7
[PMID] 17986109.
2007
Instability of IS6110 patterns in multidrug-resistant strains of Mycobacterium tuberculosis.
Epidemiology and infection.
135(2):346-52
[PMID] 17291368.
2007
Lymphocytic bronchiolitis as presenting disorder in an undiagnosed adult patient with chronic granulomatous disease.
Iranian journal of allergy, asthma, and immunology.
6(4):219-21
[PMID] 18094446.
2007
Multi-drug resistant tuberculosis in pregnancy: need for more intensive treatment.
Infection.
35(6):477-8
[PMID] 17906837.
2007
Trends of drug resistant Mycobacterium tuberculosis in a tertiary tuberculosis center in Iran.
Saudi medical journal.
28(4):544-50
[PMID] 17457475.
2006
Chronic granulomatous disease with unusual clinical manifestation, outcome, and pattern of inheritance in an Iranian family.
Journal of clinical immunology.
26(3):291-6
[PMID] 16783468.
2006
Comparison between molecular epidemiology, geographical regions and drug resistance in Mycobacterium tuberculosis strains isolated from Iranian and Afghan patients.
Chemotherapy.
52(6):316-20
[PMID] 17008783.
2006
Prevalence of Haarlem I and Beijing types of Mycobacterium tuberculosis strains in Iranian and Afghan MDR-TB patients.
The Journal of infection.
53(5):331-6
[PMID] 16476483.
2006
The most prevalent Mycobacterium tuberculosis superfamilies among Iranian and Afghan TB cases.
Scandinavian journal of infectious diseases.
38(6-7):463-8
[PMID] 16798695.
2005
Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations.
Nature genetics.
37(7):692-700
[PMID] 15924140.
2005
Inherited disorders of the IL-12-IFN-gamma axis in patients with disseminated BCG infection.
European journal of pediatrics.
164(12):753-7
[PMID] 16091917.
2005
Primary immune deficiencies presenting in adults: seven years of experience from Iran.
Journal of clinical immunology.
25(4):385-91
[PMID] 16133995.
2004
Application of oxidation-reduction assay for monitoring treatment of patients with pulmonary tuberculosis.
Journal of clinical microbiology.
42(7):3324-5
[PMID] 15243106.
2004
Bacteriological follow-up of pulmonary tuberculosis treatment: a study with a simple colorimetric assay.
Microbes and infection.
6(11):972-6
[PMID] 15345227.
Grants
Jan 2024
ACTIVE
myAirvo 3 (High Flow Nasal Therapy) for COPD patients in the home a multi-center randomized controlled trial
Role: Principal Investigator
Funding: TEMPLE UNIVERSITY
via FISHER & PAYKEL HEALTHCARE
Dec 2023
ACTIVE
A Long-term Multicenter Open-label Study to Evaluate the
Long-term Safety and Durability of Effect of XTMAB-16 in
Patients With Pulmonary Sarcoidosis With or Without
Extra-pulmonary Involvement
Role: Principal Investigator
Funding: ICON CLINICAL RESEARCH LIMITED
via XENTRIA
Dec 2023
ACTIVE
A Phase 2a, multi-center, randomized, double-blind, placebocontrolled
study to assess the efficacy and safety of ALT-100 in
patients with moderate to severe acute respiratory distress
syndrome (ARDS)
Role: Principal Investigator
Funding: NOVOTECH CLINICAL RESEARCH USA
via AQUALUNG THERAPEUTICS
Oct 2023
ACTIVE
Reparixin 1200 mg three times a day as add-on therapy to standard of care to limit disease progression in hospitalised adult patients with COVID-19 and other community-acquired pneumonia. A multinational, multicentre, randomised, double-blinded, placebo-controlled, parallel-group phase III trial.
Role: Principal Investigator
Funding: IQVIA Holdings
via DOMPE PHARMACEUTICALS
Oct 2023
ACTIVE
XTMAB-16-201
Role: Principal Investigator
Funding: ICON CLINICAL RESEARCH INC
via XENTRIA
Sep 2023
ACTIVE
A randomised, double-blind, parallel group, roll-over study
evaluating long-term safety and efficacy of oral doses of
BI 1291583 q.d. (Part A) followed by open label long-term safety
assessment (Part B) in patients with bronchiectasis (ClairleafTM)
Role: Principal Investigator
Funding: BOEHRINGER INGELHEIM INTL GmbH
Jul 2023
ACTIVE
ENCORE – A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium avium Complex (MAC)
Role: Principal Investigator
Funding: MEDIDATA
via INSMED
Jun 2023
ACTIVE
Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Escalation Study of the Safety, Tolerability, and Efficacy of Intravenous AP-SA02 as an Adjunct to Best Available Antibiotic Therapy Compared to Best Available Antibiot
Role: Principal Investigator
Funding: ARMATA PHARMACEUTICALS
via US DEPT OF DEFENSE
Feb 2023
– Sep 2024
Mechanism of action of a novel potent GM-CSF inhibitor on ex vivo sarcoidosis model
Role: Principal Investigator
Funding: KINEVANT SCIENCES
Dec 2022
ACTIVE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Prospective Study to Assess the Efficacy, Safety, and Pharmacokinetics of Orally Administered Epetraborole in Patients with Treatment-refractory Mycobacterium avium Complex Lung Disease
Role: Principal Investigator
Funding: MEDPACE
via AN2 THERAPEUTICS
Jul 2022
ACTIVE
OBERON Site Agreement
Role: Principal Investigator
Funding: DUKE UNIVERSITY CLINICAL RES INST
via ASTRAZENECA PHARM
Apr 2022
ACTIVE
A Randomized, Double-blind, Placebo-controlled, Phase 2a Multiple Ascending Dose Study to Examine the Safety, Tolerability and Efficacy of AV-001 in Patients Hospitalized with Confirmed Severe COVID-19 Disease
Role: Principal Investigator
Funding: VASOMUNE THERAPEUTICS
Apr 2022
ACTIVE
1397-0012: A randomised, double-blind, placebo-controlled, parallel group, dose-finding study evaluating efficacy, safety and tolerability of BI 1291583 qd over at least 24 weeks in patients with bronchiectasis
Role: Principal Investigator
Funding: BOEHRINGER INGELHEIM PHARM INC
Apr 2022
ACTIVE
CTA for Paratek PTK0796
Role: Principal Investigator
Funding: SYNTERACT
via PARATEK PHARMA LLC
Jan 2022
ACTIVE
A Two-Stage, Double-Blind, Placebo-Controlled Phase 2
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of OP-101 (dendrimer nacetyl-cysteine) in Patients with Severe COVID-19
Role: Principal Investigator
Funding: SYNEOS HEALTH
via ASHVATTHA THERAPEUTICS
Education
Pulmonary and Critical Care Medicine Fellowship
2015
·
University of Illinois College of Medicine at Chicago
Internal Medicine Residency
2011
·
The George Washington University/Providence Hospital
Infectious Disease Research Fellowship
2008
·
University of Louisville
Sleep Medicine Research Fellowship
2007
·
University of Louisville
Doctor of Medicine
1999
·
Qazvin University of Medical Sciences
Contact Details
Phones:
- Business:
- (904) 244-8846
Emails:
- Business:
- mehdi.mirsaeidi@jax.ufl.edu
Administrative Assistant:
Addresses:
- Business Mailing:
-
653-1 West 8th Street
Jacksonvillle FL 32611